ESPR - Esperion Therapeutics, Inc.
IEX Last Trade
2.31
0.015 0.649%
Share volume: 55,456
Last Updated: Fri 27 Dec 2024 08:30:04 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$2.30
0.02
0.65%
Summary score
35%
Profitability
30%
Dept financing
35%
Liquidity
75%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-30.22%
Return on assets
-13.1%
Return on sales
-397.09%
Return on invested capital
102.78%
Total debt ratio
198.97%
Debt ratio change over timeo
0.74%
Current Ratio
2.87%
Quick Ratio
2.53%
Cash Position Ratio
2.14%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.78%
Return on assets
-7.36%
Return on sales
-75.92%
Return on invested capital
19.17%
Total debt ratio
260.95%
Debt ratio change over timeo
0.84%
Current Ratio
1.81%
Quick Ratio
1.4%
Cash Position Ratio
1.01%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-20.73%
Return on assets
19.37%
Return on sales
52.47%
Return on invested capital
-38.85%
Total debt ratio
178.89%
Debt ratio change over time
3.81%
Current Ratio
2.22%
Quick Ratio
1.78%
Cash Position Ratio
1.38%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-38.91%
Return on assets
-106.7%
Return on sales
-305.84%
Return on invested capital
-33.65%
Total debt ratio
74.39%
Debt ratio change over time
0.74%
Current Ratio
1.7%
Quick Ratio
1.37%
Cash Position Ratio
0.97%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ESPR | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -30.22% | 18.83% | 17.34% | 7.6% |
| Return on assets | -13.1% | 4.16% | 8.21% | 3.22% |
| Return on sales | -397.09% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 102.78% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 57% | 73% | 37% |
| Total debt ratio | 198.97% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | 0.74% | -4.38% | -0.73% | -33.74% |
| Dept financing | 50% | 10% | 7% | 8% |
| Current Ratio | 1.81% | 1.12% | 0% | 1.16% |
| Quick Ratio | 1.4% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 1.01% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 22% | 22% | 28% |
| Short-term ratios | ESPR | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 3.78% | 13.31% | 0% | 13.48% |
| Return on assets | -7.36% | 4.72% | 0% | 3.05% |
| Return on sales | -75.92% | 31.4% | 0% | 25.56% |
| Return on invested capital | 19.17% | 10.68% | 0% | 13.96% |
| Profitability | 32% | 89% | 0% | 80% |
| Total debt ratio | 260.95% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | 0.84% | -41.82% | 0% | 7.13% |
| Dept financing | 28% | 8% | 0% | 31% |
| Current Ratio | 1.81% | 1.12% | 0% | 1.16% |
| Quick Ratio | 1.4% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 1.01% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 34% | 0% | 45% |